ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.98
+1.68 (13.66%)
Sep 5, 2025, 4:08 PM HKT

HKG:1541 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
405.4477.6306.98635.21668.33
Short-Term Investments
--42.5--
Trading Asset Securities
298.3274.52259.09--
Cash & Short-Term Investments
703.7752.12608.56635.21668.33
Cash Growth
37.16%23.59%-4.20%-4.96%-
Accounts Receivable
0.010.020.040.070.03
Other Receivables
14.150.171.040.960.02
Receivables
14.160.181.081.020.06
Inventory
7.8824.5476.779.0419.42
Other Current Assets
091.090.296.5916.3
Total Current Assets
725.74867.94686.7651.87704.1
Property, Plant & Equipment
39.6347.71149.39163.89154.12
Other Long-Term Assets
5.876.3538.524.2234.62
Total Assets
771.24922874.59839.98892.84
Accounts Payable
14.3543.2410.81.261.76
Accrued Expenses
37.2128.5930.8628.9124.17
Short-Term Debt
--59.98--
Current Portion of Long-Term Debt
127.99100.89---
Current Portion of Leases
6.396.424.45.65.1
Current Income Taxes Payable
0.691.110.770.612.96
Current Unearned Revenue
30.9232.9---
Other Current Liabilities
0.481.499.1115.362,444
Total Current Liabilities
218.02214.64115.9151.742,478
Long-Term Debt
914.5---
Long-Term Leases
10.3414.5510.49.0213.44
Total Liabilities
237.36243.69126.360.762,491
Common Stock
407.31407.31374.16356.096.91
Additional Paid-In Capital
-1,093913.46654.47-
Retained Earnings
--1,026-710.35-330.89-1,638
Comprehensive Income & Other
127.31205.21171.0199.5432.24
Total Common Equity
534.62678.9748.29779.22-1,598
Minority Interest
-0.73-0.6---
Shareholders' Equity
533.88678.31748.29779.22-1,598
Total Liabilities & Equity
771.24922874.59839.98892.84
Total Debt
153.72136.3674.7714.6218.54
Net Cash (Debt)
549.98615.76533.79620.59649.79
Net Cash Growth
32.42%15.36%-13.99%-4.49%-
Net Cash Per Share
1.401.631.481.877.54
Filing Date Shares Outstanding
407.31407.31374.16356.0986.18
Total Common Shares Outstanding
407.31407.31374.16356.0986.18
Working Capital
507.72653.3570.79600.13-1,774
Book Value Per Share
1.311.672.002.19-18.55
Tangible Book Value
534.62678.9748.29779.22-1,598
Tangible Book Value Per Share
1.311.672.002.19-18.55
Machinery
-52.8951.4449.9340.87
Construction In Progress
-27.422.6922.463.22
Leasehold Improvements
-22.4922.4922.4921.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.